Revium Rx (RVRC) Enterprise Value (2024 - 2025)

Revium Rx (RVRC) reported Enterprise Value of -$2.7 million for Q4 2025, up 39.88% on a YoY basis from -$1.9 million in Q4 2024, and up 39.88% sequentially from -$4.5 million in Q4 2024.

Revium Rx (RVRC) Enterprise Value (2024 - 2025) Analysis & Trends

Revium Rx (RVRC) has 2 years of Enterprise Value data on file, last reported at -$2.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value rose 39.88% year-over-year to -$2.7 million; the trailing twelve-month figure through Dec 2025 stood at -$2.7 million (up 39.88% YoY), and the FY2025 full-year result was -$2.7 million, up 39.88% from the prior year.
  • Enterprise Value advanced to -$2.7 million in Q4 2025, from -$4.5 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$2.7 million in Q4 2025 to a low of -$4.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Veeva Systems 31.61 Bn 24.30 Bn 662.02 Mn -7.31 Bn
2 BrightSpring Health Services 14.73 Bn 13.83 Bn 482.22 Mn -900.97 Mn
3 Healthequity 8.26 Bn 8.00 Bn 256.31 Mn -265.37 Mn
4 Hinge Health 5.90 Bn 5.58 Bn 154.23 Mn -315.87 Mn
5 10x Genomics 5.90 Bn 5.36 Bn 106.18 Mn -539.85 Mn
6 MiniMed 4.52 Bn 4.22 Bn 480.00 Mn -298.00 Mn
7 Waystar Holding 4.42 Bn 4.36 Bn 216.84 Mn -62.70 Mn
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn -748.60 Mn
9 Privia Health 3.17 Bn 2.75 Bn - -366.68 Mn
10 Revium Rx 101.42 Mn 98.71 Mn - -2.71 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.71 Mn
Dec 31, 2024 -4.51 Mn